Type 2 Diabetes
Conditions
Brief summary
The study objectives are: 1. To compare cardiovascular function in type 2 diabetes patients vs. healthy controls. 2. To compare the effect of 8 weeks of aerobic interval training versus continuous moderate exercise on cardiovascular function in adults with type 2 diabetes. 3. To examine the mechanisms underlying the exercise-related changes in cardiovascular function. The investigators hypothesize that compared to continuous moderate intensity exercise training, interval training will be more effective in improving cardiovascular function in adults with type 2 diabetes.
Detailed description
Cardiovascular function will be measured at baseline in adults with type 2 diabetes and in age-matched healthy controls. Research volunteers with type 2 diabetes who meet the inclusion criteria will be randomized to the aerobic interval training group, continuous moderate exercise group or non-exercise control group. At the end of the 8-week randomized control exercise intervention, baseline measures will be repeated.
Interventions
Supervised aerobic interval training will be performed on bicycles 4 times per week for 8 weeks. Each training session will last 40 minutes and will consist of 10-minute warm up at 70% of maximal heart rate (HRmax), four 4-minute intervals at 90% of HRmax with 3-min active recovery at 70% of HRmax and 5-minute cool down at 70% of HRmax.
Supervised exercise training will be performed on bicycles 4 times per week for 8 weeks. Each training session will last 47 minutes and will consist of continuous moderate intensity cycling at 70% of HRmax.
Sponsors
Study design
Eligibility
Inclusion criteria
for type 2 diabetes : * Diagnosis of type 2 diabetes * Sedentary or minimally physically active for at least the prior 1 year * Able to give consent Inclusion criteria for healthy control group: * Sedentary or minimally physically active for at least the prior 1 year * Able to give consent
Exclusion criteria
* History of diabetic proliferative retinopathy, autonomic or peripheral neuropathy * History of any relevant cardiovascular diseases (myocardial infarction, angina pectoris, history of coronary artery bypass surgery or angioplasty, congestive heart failure, or arrhythmia) * Hypertension (≥160 mmHg systolic or ≥100 mmHg diastolic) * History of renal impairment * History of gout or hyperuricemia * History of hepatic disease or infection with hepatitis B, C * History of seizures, or other relevant on-going or recurrent illness * Recent (within 3 months) or recurrent hospitalizations * Use of tobacco products * \>5 % weight change in the prior 6 months. * Current intake of medications that may affect study results * Premenopausal women taking oral contraceptives and postmenopausal women taking hormone replacement therapy. * Pregnancy (positive urine pregnancy test) or lactation * For the healthy control group, history of diabetes.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in vascular endothelial function | At baseline and after 8 weeks of exercise training | Brachial flow mediated dilation using ultrasonography |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in factors related with endothelial function | At baseline and after 8 weeks of exercise training | Blood and cellular markers of adiponectin, oxidative stress and inflammation. |
| Change in arterial stiffness | At baseline and after 8 weeks of exercise training | Arterial stiffness (pulse wave velocity) and wave reflection (augmentation index) will be measured using the SphygmoCor device. |
| Change in cardiac function | At baseline and after 8 weeks of exercise training | Left ventricular systolic and diastolic function will be measured using echocardiography. |
| Change in maximal oxygen consumption | At baseline and after 8 weeks of exercise training | Maximal oxygen consumption will be measured using online computer-assisted open-circuit spirometry during incremental treadmill exercise. |
Countries
United States